Skip to main content
Fig. 1 | BMC Family Practice

Fig. 1

From: Is therapeutic inertia present in hyperglycaemia, hypertension and hypercholesterolaemia management among adults with type 2 diabetes in three health clinics in Malaysia? a retrospective cohort study

Fig. 1

Anti-diabetic, anti-hypertensive and lipid-lowering therapeutic changes when their respective treatment targets were not achieved in year 2015. Sample size included: ADA, n = 367; Insulin, n = 365; AHA, n = 218; LLA, n = 206. ADA = oral anti-diabetic agents; AHA = anti-hypertensive agents; LLA = lipid-lowering agents; LDL-C = low-density lipoprotein cholesterol. Chi-square: differences in the three clinics for: ADA χ2 = 9.161, P = 0.057; Insulin χ2 = 15.410, P = 0.004. AHA χ2 = 27.953, P < 0.001; LLA χ2 = 6.634, P = 0.157

Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us